Medical devices, healthcare technology and the business of care
510(k) clearance · K260676

Radius VSM and Accessories

Masimo Corporation · Decision date Oct 14, 2026

MEDTECHLEDGER EXPLANATIONK260676

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 14 October 2026 for K260676, submitted by Masimo Corporation of Irvine, California, covering the device named Radius VSM and Accessories. The application was received on 2 March 2026 and listed as a Traditional 510(k) reviewed by FDA rather than a third party; it was not recorded as a combination product, and no predetermined change control plan was authorized. SESE in this 510(k) context denotes clearance, not PMA approval.

The record classifies the device under regulation 870.1025 as a physiological patient monitor with arrhythmia detection or alarms, with primary product code MHX and subsequent codes including BZQ, DPS, DPZ, DQA, DQK, DRT, DSI, DSJ, DXN, DXQ, FLL and KMI. The regulation medical specialty and review panel are both Cardiovascular. The source does not include the indications for use, the components or accessories covered, performance data, or the predicate device, so the basis for the equivalence determination remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 14, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260676
Regulatory pathway
510(k) premarket notification
Product code
MHX
Decision code
SESE
Decision date
Oct 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).

Product code
MHX
FDA device class
2

FDA decision timeline

  1. K260676 received

    Application receipt date recorded by FDA.

  2. K260676 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MHX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Masimo Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Irvine, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records